2021-01-07,"Zacks.com featured highlights include: Bellicum Pharmaceuticals, Prometic Life Sciences, Vaccinex, Meridian Bioscience and 360 DigiTech"
2021-01-06,Bet on Rising P/E With These 5 Top-Ranked Stocks
2021-01-05,Vaccinex to Participate in the LifeSci Partners 10th Annual Healthcare Corporate Access Event
2020-11-13,Vaccinex Reports Third Quarter 2020 Financial Results and Provides Corporate Update
2020-10-29,CORRECTION -- Vaccinex to Present Additional SIGNAL Data at Huntington Study Group 2020 Medical Conference
2020-10-26,"Vaccinex, Inc. to Present at the Virtual Investor KOL Roundtable"
2020-10-12,Implied Volatility Surging for Vaccinex (VCNX) Stock Options
2020-09-23,"Biotech Stock Roundup: Bristol-Myers' Updates, VCNX's Disappointing Data & More"
2020-09-22,Vaccinex's stock falls after investigational drug fails Huntington's disease study
2020-09-22,Top-Line Results of Phase 2 SIGNAL Study in Huntingtons Disease Support Potential for Cognitive Benefit of Pepinemab
2020-09-17,"Vaccinex Announces Clinical Collaboration with Merck to Evaluate Pepinemab in Combination with KEYTRUDA® in Advanced, Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma"
2020-08-27,Vaccinex Announces Appointment of Robert Scala as Chief Commercial Officer
2020-08-14,"Vaccinex, Inc. (VCNX) Reports Q2 Loss, Misses Revenue Estimates"
2020-08-14,Vaccinex Reports Second Quarter 2020 Financial Results and Provides Corporate Update
2020-08-05,"Vaccinex, Inc. (VCNX) May Report Negative Earnings: Know the Trend Ahead of Q2 Release"
2020-07-16,3 Stocks Flashing Signs of Strong Insider Buying
2020-07-07,Vaccinex (VCNX) Catches Eye: Stock Jumps 8.1%
2020-07-07,Vaccinex Provides Update of Potentially Pivotal SIGNAL Clinical Trial in Huntingtons Disease
2020-06-09,"Vaccinex, Inc. to Present at the Virtual Investor Fireside Chat Series"
2020-05-14,"Vaccinex Inc (VCNX) Reports Q1 Loss, Lags Revenue Estimates"
2020-05-14,Vaccinex Reports First Quarter 2020 Financial Results and Provides Corporate Update
2020-05-13,"Vaccinex to Present Updated Results from CLASSICAL-Lung, Phase 1b/2 Study of Pepinemab (VX15/2503) in Combination with Avelumab (BAVENCIO®) in Non-Small Cell Lung Cancer at the American Society of Clinical Oncology (ASCO) 2020 Annual Meeting"
2020-05-13,Vaccinex Inc (VCNX) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
2020-04-27,"Updated Interim Results from CLASSICAL-Lung, Phase 1b/2 Study of Pepinemab (VX15/2503) in Combination with Avelumab (BAVENCIO®) in Non-Small Cell Lung Cancer Presented at the American Association for Cancer Research (AACR) Virtual Annual Meeting"
2020-04-07,Vaccinex Delivers Virtual Presentation at the Advances in Alzheimers and Parkinsons Therapies AAT-AD/PD Focus Meeting 2020
2020-03-31,Vaccinex Announces up to $16.5 Million in Equity Financing Agreements and Provides an Update on COVID-19 Impact on its Clinical Programs
2020-03-09,Vaccinex Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
2020-02-06,Vaccinex Announces Three Oral Presentations Highlighting Semaphorin 4D (SEMA4D) at the ASCO-SITC Clinical Immuno-Oncology Symposium
2019-12-10,Vaccinex Announces $3 Million Award from the Alzheimers Drug Discovery Foundation
2019-12-09,Vaccinex Details Scientific Rationale for Expanding Pepinemab Clinical Programs to Include Alzheimers Disease
2019-11-25,"Is Vaccinex, Inc. (VCNX) Burning These Hedging Funds ?"
2019-11-14,Vaccinex Announces Award Notice from the Alzheimers Association 2020 Part the Cloud Program
2019-11-12,Vaccinex Reports Third Quarter 2019 Financial Results and Provides Corporate Update
2019-11-09,Vaccinex Presents Updated Interim Data from a Phase 1b/2 Study of Pepinemab (VX15/2503) in Combination with Avelumab (BAVENCIO®) in Non-Small Cell Lung Cancer at the 34th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
2019-10-31,Orgenesis Appoints Bala S. Manian to its Scientific Advisory Board
2019-09-27,"Vaccinex Presents Updated Interim Data from a Phase 1b/2 Study of Pepinemab (VX15/2503) in Combination with Avelumab (BAVENCIO®) in Non-Small Cell Lung Cancer in Podium and Poster Presentations at the Fifth International Cancer lmmunotherapy Conference in Paris, France"
2019-09-24,Vaccinex to Present at the Ladenburg Thalmann 2019 Healthcare Conference
2019-09-06,"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Vaccinex, Inc.- VCNX"
2019-08-14,Vaccinex (VCNX) Attains Full Enrollment in Lung Cancer Study
2019-08-14,Vaccinex Reports Second Quarter 2019 Financial Results and Provides Corporate Update
2019-08-13,Vaccinex Announces Full Enrollment Achieved in Ongoing CLASSICAL-Lung Phase 1b/2 Trial of Pepinemab in Combination with BAVENCIO® (avelumab) in Advanced Non-Small Cell Lung Cancer
2019-08-12,"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Vaccinex, Inc.- VCNX"
2019-08-02,Insiders Roundup: Bezos Sells Amazon
2019-08-01,"Vaccinex Inc (VCNX) President and CEO Maurice Zauderer Bought $750,002 of Shares"
2019-07-31,Vaccinex Announces $13.8 Million Private Placement
2019-06-03,Vaccinex Presents Updated Interim Results from a Phase 1b/2 Study of Pepinemab in Combination with Avelumab in Non-Small Cell Lung Cancer at the 2019 ASCO Annual Meeting
2019-05-15,Vaccinex Announces Poster Presentations at the 2019 ASCO Annual Meeting
2019-05-15,Vaccinex Reports First Quarter 2019 Financial Results and Provides Corporate Update
2019-04-09,"Vaccinex, Inc. Summary of Key Data Presented at the 2019 Annual Meeting of the American Association for Cancer Research (AACR)"
2019-04-01,"Vaccinex, Inc. to Provide Clinical Data on Posters Presented at the 2019 Annual Meeting of the American Association for Cancer Research (AACR)"
2019-03-13,"Vaccinex, Inc. to Present at the Oppenheimer & Co. 29th Annual Healthcare Conference on March 19, 2019"
2019-03-13,Vaccinex Reports Fourth Quarter 2018 Financial Results and Provides Corporate Update
2019-03-06,"Vaccinex, Inc. to Present Data on Its Anti-SEMA4D Compound at the American Association for Cancer Research Annual Meeting 2019"
2019-01-17,"Vaccinex, Inc. Presented Previously Disclosed Data from Ongoing Phase 1/2 Trial of VX15/2503 (Pepinemab) in Huntingtons Disease (the SIGNAL Trial) at Cambridge Healthtech Institutes 18th Annual PepTalk"
2019-01-16,"Vaccinex, Inc. Announces Completion of Enrollment for Its SIGNAL Huntingtons Disease Trial"
2018-12-12,"Do Insiders Own Lots Of Shares In Vaccinex, Inc. (NASDAQ:VCNX)?"
2018-12-12,"Preclinical Data on Vaccinex, Inc. Anti-SEMA4D Monoclonal Antibody in Combination with Checkpoint Inhibitors Published in Cancer Immunology Research"
2018-11-27,"Vaccinex, Inc. to Present at the 11th Annual LD Micro Main Event"
2018-11-15,"Vaccinex, Inc. Gives Podium Presentation and Poster at the Society for Immunotherapy of Cancer Annual Meeting"
2018-11-13,Vaccinex Reports Third Quarter 2018 Financial Results and Provides Corporate Update
2018-11-12,"Vaccinex, Inc. Presents Overview of the Clinical Development of VX15 (pepinemab) for the Potential Treatment of Huntingtons Disease at the Huntington Study Groups 2018 Annual Meeting"
2018-11-06,"Vaccinex, Inc. to Present Data on Its Semaphorin 4D Monoclonal Antibody Programs at Two Conferences Focused on Cancer Immunotherapy and Huntingtons Disease"
2018-10-23,"Vaccinex, Inc. to Participate on a Panel and Meet with Investors at the BTIG Healthcare Conference October 25, 2018"
2018-10-02,"Vaccinex, Inc. Presents Preliminary Data on Its Anti-Semaphorin 4D Monocolonal Antibody Technology at the Fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference"
2018-09-27,"Vaccinex, Inc. to Participate in Podium and Poster Sessions at the Fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference"
2018-09-25,"Vaccinex, Inc. to Present at the Ladenburg Thalmann 2018 Healthcare Conference"
2018-09-13,Why Did Vaccinex Incs (NASDAQ:VCNX) Insiders Buy Up More Shares?
2018-09-04,Oppenheimer: Vaccinex Has Catalysts In Novel Therapies For Challenging Diseases
2018-08-09,Vaccinex shares slide 3% on their first day of trade
2018-08-09,"Vaccinex prices IPO at $12, low end of price range"
2018-08-09,Vaccinex Announces Pricing of Initial Public Offering
2018-08-05,"The IPO Outlook For The Week: An Airline, A Biotech And 2 Banks"
